Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Reviva Pharmaceuticals Holdings, Inc. (RVPH) had Weighted-Average Shares Outstanding (Diluted) of 3.63M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-3.37M |
|
-- |
|
-- |
|
$3.56M |
|
$-3.56M |
|
$0.19M |
|
$-3.36M |
|
$-3.36M |
|
$-3.37M |
|
$-3.37M |
|
$-3.37M |
|
$-3.37M |
|
$-3.56M |
|
$-3.56M |
|
3.63M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
3.63M |
$0.72 |
|
$0.72 |
|
| Balance Sheet Financials | |
$15.10M |
|
-- |
|
$0.82M |
|
$15.92M |
|
$7.28M |
|
-- |
|
-- |
|
$7.28M |
|
$8.65M |
|
$8.65M |
|
$8.65M |
|
5.87M |
|
| Cash Flow Statement Financials | |
$-24.59M |
|
-- |
|
$25.56M |
|
$13.48M |
|
$14.44M |
|
$0.96M |
|
$2.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.08 |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-24.59M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-38.94% |
|
-38.94% |
|
-21.15% |
|
-38.94% |
|
$1.47 |
|
$-6.78 |
|
$-6.78 |
|